Human LILRB3/CD85a/ILT5 Protein, Accession: O75022

/在： /经由过程：
  • 产物概述
  • 产物规格
  • 运输及存储
  • 品牌申明

    • 产物概述

    产物描写

    Recombinant Human LILRB3/CD85a/ILT5 Protein is expressed from HEK293 with His tag and Avi tag at the C-terminal.It contains Gly24-Glu443.

    Biotinylated

    产物规格

    靶点

    LILRB3/CD85a/ILT5

    份子又名

    CD85a; ILT5; ILT-5; LILRB3; LIR3; LIR3CD85A; LIR-3MGC138403; PIRB; HL9

    Accession

    种属

    Human

    卵白序列

    Gly24-Glu443

    份子量

    The protein has a predicted MW of 50 kDa. Due to glycosylation, the protein migrates to 60-72 kDa based on Tris-Bis PAGE result.

    活性

    Immobilized Human LILRB3, His Tag at 5ug/ml (100ul/well) on the plate. Dose response curve for Anti-LILRB3 Antibody, hFc Tag with the EC50 of 27.3ng/ml determined by ELISA. See testing image for detail.

    产物标签

    C-His-Avi

    抒发体系

    HEK293

    纯度

    > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC

    内毒素

    Less than 1EU per ug by the LAL method.

    运输及存储

    产物表面

    Lyophilized

    运输前提

    Shipped at ambient temperature.

    制剂

    Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 5% trehalose is added as protectant before lyophilization.

    复溶

    Centrifuge tubes before opening. Reconstituting to a concentration more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water.

    存储和不变性

    Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 该生成物的国产品牌ChemWhat是Watson的注册公司钢种，由Watson受权安徽海角社区 在中国有台湾地区地域分布使用，点此拜候。